Canine Atopic Dermatitis with Dr. Darren Berger, DACVD

Cost

Free/Sponsored

Related Disciplines:

November 2024

In today’s VETgirl online veterinary CE podcast, we talk to Dr. Darren J Berger, DACVD on all things Canine Atopic Dermatitis (CAD). In veterinary medicine, we see atopy a ton, but we still see a lot of “failure” in treatment! Tune in to learn what we can do to better treat CAD, how to prevent our pet owners from getting so frustrated by it, and when to refer these cases to a dermatologist! Learn what your ultimate goal is in treating pruritic dogs, and what’s the latest innovation in treating dogs with CAD!

Today’s VETgirl podcast is brought to you by Elanco, makers of Zenrelia™ (ilunocitinib tablets). Get dogs back to normal with the new, once-daily JAK inhibitor for dogs over 12 months of age with allergic dermatitis and atopic dermatitis. For more information, visit my.elanco.com/us/zenrelia.

INDICATIONS
Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

IMPORTANT SAFETY INFORMATION
Read the entire package insert before using this drug, including the Boxed Warning.
For Full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to opportunistic infections. Neoplastic conditions (benign and malignant) were observed during clinical studies. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert.

Elanco logo

Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2024 Elanco or its affiliates. Podcast PM-US-24-1750.

Today’s VETgirl podcast is sponsored by Elanco. Please note the opinions in this podcast are the expressed opinion of the speaker(s)/sponsor, and not directly endorsed by VETgirl. Please note: Dr. Darren Berger, DACVD is employed by Elanco.

Not a VETgirl ELITE member? Get your learning on with the #1 veterinary CE resource – clinically relevant, practical, and accessible 24/7 on your own time! Don’t miss out – click HERE to check out your options, including our new  14-day, no-commitment ELITE Trial.

Only VETgirl members can leave comments. Sign In or Join VETgirl now!